Literature DB >> 1650757

Molecular and cellular analysis of human T lymphocytes expressing gamma delta T-cell receptor.

L Moretta1, E Ciccone, S Ferrini, P G Pelicci, M C Mingari, J Zeromski, C Bottino, C Grossi, A Moretta.   

Abstract

A minor subset of T lymphocytes expresses a CD3-associated TCR composed of gamma and delta chains. The majority of TCR gamma/delta+ cells lack surface CD4 and CD8 antigen and do not react with WT31 mAb. These negative criteria were utilized in early studies to identify TCR gamma/delta+ cells. More recently, mAb to TCR gamma/delta, selected in different laboratories, have permitted the direct identification of TCR gamma/delta+ cells and their subsets. TCR gamma/delta molecules were found to be heterogeneous in size and charge mobility. Two major forms of TCR gamma/delta could be identified that are characterized by the presence or absence of an inter-chain disulphide bond. Biochemical analysis originally suggested that a precise correlation existed between reactivity with BB3 or delta TCS1/A13 mAb and expression of a disulphide (C gamma 1-encoded) or non-disulphide linked (C gamma 2-encoded) form of TCR gamma/delta. However, more recent studies have indicated that these mAb react with the molecular product of V delta 2 or V delta 1, respectively, mAb directed to one or another form of TCR gamma/delta activate the functional program of the cell, leading to intracellular Ca++ mobilization, lymphokine production and triggering of the lytic machinery. Analysis of the target molecules for TCR gamma/delta-mediated recognition revealed that at least some TCR gamma/delta+ cells are capable of specific responses to (allo)antigen and that polymorphic determinants of class I molecules can be recognized (as shown by the specific lysis of P815 cells transfected with HLA-24 allele). Unlike TCR alpha/beta+ cells, TCR gamma/delta+ cells are homogeneously composed of cytolytic precursors, as shown by the analysis of a large panel of clones in both lectin-dependent and redirected killing assays. In spite of their LGL morphology, freshly isolated TCR gamma/delta+ cells do not lyse NK-sensitive targets but do so after exposure to rIL-2. A modest cytolytic activity, however, could be induced also in fresh cells by anti-TCR/CD3 mAb in a redirected killing assay. Analysis of the distribution of the subsets expressing different TCR gamma/delta types showed that BB3+ cells are prevalent in the peripheral blood and virtually absent in the thymus; in contrast, A13+ (delta TCS1+) cells represent the majority of TCR gamma/delta+ thymocytes. Electron microscopic analysis of fresh TCR gamma/delta+ cells showed an extended cytoplasm containing numerous electron-dense granules identifiable as primary lysosomes. Upon stimulation with IL-2, TCR gamma/delta+ cells, similar to other LAK cells, display an increase in their cytoplasmic granules together with a redistribution of cytoskeletal structures.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1650757     DOI: 10.1111/j.1600-065x.1991.tb00590.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  11 in total

1.  Characterization of avian T-cell receptor gamma genes.

Authors:  A Six; J P Rast; W T McCormack; D Dunon; D Courtois; Y Li; C H Chen; M D Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

2.  T-B+NK+ severe combined immunodeficiency caused by complete deficiency of the CD3zeta subunit of the T-cell antigen receptor complex.

Authors:  Joseph L Roberts; Jens Peter H Lauritsen; Myriah Cooney; Roberta E Parrott; Elisa O Sajaroff; Chan M Win; Michael D Keller; Jeffery H Carpenter; Juan Carabana; Michael S Krangel; Marcella Sarzotti; Xiao-Ping Zhong; David L Wiest; Rebecca H Buckley
Journal:  Blood       Date:  2006-12-14       Impact factor: 22.113

3.  Clonal expansion of lung V delta 1+ T cells in pulmonary sarcoidosis.

Authors:  J M Forrester; L S Newman; Y Wang; T E King; B L Kotzin
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

4.  Extrathymic differentiation of T lymphocytes and natural killer cells from human embryonic liver precursors.

Authors:  A Poggi; M Sargiacomo; R Biassoni; N Pella; S Sivori; V Revello; P Costa; M Valtieri; G Russo; M C Mingari
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

5.  Thymocyte-thymic epithelial cell interaction leads to high-level replication of human immunodeficiency virus exclusively in mature CD4(+) CD8(-) CD3(+) thymocytes: a critical role for tumor necrosis factor and interleukin-7.

Authors:  L Chêne; M T Nugeyre; E Guillemard; N Moulian; F Barré-Sinoussi; N Israël
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

6.  The surface epithelium of recurrent infected palatine tonsils is rich in gammadelta T cells.

Authors:  K Olofsson; S Hellström; M L Hammarström
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

7.  Gamma delta lymphocytes in endocrine autoimmunity: evidence of expansion in Graves' disease but not in type 1 diabetes.

Authors:  I C Roura-Mir; L Alcalde; F Vargas; E Tolosa; G Obiols; M Foz; D Jaraquemada; R Pujol-Borrell
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

8.  Functional analysis of TCR gamma delta+ T cells in tumour-infiltrating lymphocytes (TIL) of human pancreatic cancer.

Authors:  J Kitayama; Y Atomi; H Nagawa; A Kuroda; T Mutoh; M Minami; T Juji
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

9.  Infiltrating gamma/delta T-cell receptor-positive lymphocytes in Hashimoto's thyroiditis, Graves' disease and papillary thyroid cancer.

Authors:  F Paolieri; C Pronzato; M Battifora; N Fiorino; G W Canonica; M Bagnasco
Journal:  J Endocrinol Invest       Date:  1995-04       Impact factor: 4.256

10.  A novel mechanism of soluble HLA-G mediated immune modulation: downregulation of T cell chemokine receptor expression and impairment of chemotaxis.

Authors:  Fabio Morandi; Elisa Ferretti; Paola Bocca; Ignazia Prigione; Lizzia Raffaghello; Vito Pistoia
Journal:  PLoS One       Date:  2010-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.